JP2016512207A5 - - Google Patents

Download PDF

Info

Publication number
JP2016512207A5
JP2016512207A5 JP2015561958A JP2015561958A JP2016512207A5 JP 2016512207 A5 JP2016512207 A5 JP 2016512207A5 JP 2015561958 A JP2015561958 A JP 2015561958A JP 2015561958 A JP2015561958 A JP 2015561958A JP 2016512207 A5 JP2016512207 A5 JP 2016512207A5
Authority
JP
Japan
Prior art keywords
hydroxybutyrate
skin
composition
ketone body
ketone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015561958A
Other languages
English (en)
Japanese (ja)
Other versions
JP6375315B2 (ja
JP2016512207A (ja
Filing date
Publication date
Priority claimed from GBGB1304467.2A external-priority patent/GB201304467D0/en
Application filed filed Critical
Publication of JP2016512207A publication Critical patent/JP2016512207A/ja
Publication of JP2016512207A5 publication Critical patent/JP2016512207A5/ja
Application granted granted Critical
Publication of JP6375315B2 publication Critical patent/JP6375315B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015561958A 2013-03-12 2013-09-16 皮膚の保護に使用するための化合物 Active JP6375315B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1304467.2A GB201304467D0 (en) 2013-03-12 2013-03-12 Compound for use in protecting skin
GB1304467.2 2013-03-12
PCT/EP2013/069189 WO2014139599A1 (en) 2013-03-12 2013-09-16 Compound for use in protecting skin

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018060110A Division JP6789263B2 (ja) 2013-03-12 2018-03-27 皮膚の保護に使用するための化合物

Publications (3)

Publication Number Publication Date
JP2016512207A JP2016512207A (ja) 2016-04-25
JP2016512207A5 true JP2016512207A5 (enExample) 2016-06-09
JP6375315B2 JP6375315B2 (ja) 2018-08-15

Family

ID=48189804

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2015561958A Active JP6375315B2 (ja) 2013-03-12 2013-09-16 皮膚の保護に使用するための化合物
JP2018060110A Active JP6789263B2 (ja) 2013-03-12 2018-03-27 皮膚の保護に使用するための化合物
JP2020114922A Active JP7267244B2 (ja) 2013-03-12 2020-07-02 皮膚の保護に使用するための化合物
JP2022194392A Pending JP2023029344A (ja) 2013-03-12 2022-12-05 皮膚の保護に使用するための化合物

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2018060110A Active JP6789263B2 (ja) 2013-03-12 2018-03-27 皮膚の保護に使用するための化合物
JP2020114922A Active JP7267244B2 (ja) 2013-03-12 2020-07-02 皮膚の保護に使用するための化合物
JP2022194392A Pending JP2023029344A (ja) 2013-03-12 2022-12-05 皮膚の保護に使用するための化合物

Country Status (10)

Country Link
US (3) US10821062B2 (enExample)
EP (2) EP4714505A2 (enExample)
JP (4) JP6375315B2 (enExample)
AU (1) AU2013382361B2 (enExample)
CA (1) CA2905545C (enExample)
DK (1) DK2968091T3 (enExample)
ES (1) ES3059181T3 (enExample)
GB (2) GB201304467D0 (enExample)
HK (1) HK1220382A1 (enExample)
WO (1) WO2014139599A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004245567B2 (en) 2003-06-03 2011-06-23 Oxford University Innovation Limited Nutritional supplements and therapeutic compositions comprising (R)-3-hydroxybutyrate derivatives
EP2240017B1 (en) 2008-01-04 2019-03-13 Oxford University Innovation Limited Ketone bodies and ketone body esters as blood lipid lowering agents
US8642654B2 (en) 2009-04-16 2014-02-04 Isis Innovation Limited Hydroxybutyrate ester and medical use thereof
GB201002983D0 (en) 2010-02-22 2010-04-07 Tdeltas Ltd Nutritinal composition
JP6883384B2 (ja) * 2012-11-05 2021-06-09 ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ 電離放射線による傷害から組織を防護するためのケトン体
GB201304467D0 (en) 2013-03-12 2013-04-24 Tdeltas Ltd Compound for use in protecting skin
SG11201507685UA (en) 2013-03-14 2015-10-29 Isis Innovation Process for producing (r)-3-hydroxybutyl (r)-3-hydroxybutyrate
US9255059B2 (en) 2013-08-02 2016-02-09 Eastman Chemical Company Method for producing an alkyl 3-hydroxybutyrate
US9249378B2 (en) 2013-08-02 2016-02-02 Eastman Chemical Company Aqueous cleaning compositions having enhanced properties
US9388114B2 (en) 2013-08-02 2016-07-12 Eastman Chemical Company Compositions including an alkyl 3-hydroxybutyrate
US9163202B2 (en) 2013-08-02 2015-10-20 Eastman Chemical Company Aqueous cleaning compositions including an alkyl 3-hydroxybutyrate
US20180057846A1 (en) 2016-08-30 2018-03-01 KetoneAid Inc. Partially buffered free acid and/or ketone blend for rapid onset ketosis and metabolic therapy
JP6804352B2 (ja) * 2017-03-22 2020-12-23 大阪瓦斯株式会社 コラゲナーゼmmp1及び3の産生抑制剤
JP2018158898A (ja) * 2017-03-22 2018-10-11 大阪瓦斯株式会社 トロポエラスチン発現促進剤
JP2018158899A (ja) * 2017-03-22 2018-10-11 大阪瓦斯株式会社 抗酸化系酵素群産生促進剤
CN109394745A (zh) * 2017-08-17 2019-03-01 博瑞生物医药(苏州)股份有限公司 一种包含左旋肉碱和β-羟基丁酸化合物的组合物
US11760963B2 (en) 2017-08-23 2023-09-19 KetoneAid Inc. Ketogenic beer and alcoholic beverage mixture containing non-racemic ethyl 3-hydroxybutyrate and/or 1,3 butanediol
JP6979918B2 (ja) * 2018-03-30 2021-12-15 大阪瓦斯株式会社 ヒト老化細胞賦活剤
JP6979919B2 (ja) * 2018-03-30 2021-12-15 大阪瓦斯株式会社 ヒト正常細胞賦活剤
ES2911191T3 (es) * 2018-04-05 2022-05-18 Beiersdorf Ag Composición cosmética para una rápida evaporación del sudor
GB2575623B (en) * 2018-06-04 2022-10-26 Tdeltas Ltd 3-hydroxybutyrate esters for treating cancer cachexia
WO2021195477A1 (en) 2020-03-27 2021-09-30 Ketoneaid, Inc. Ketone ester as a therapeutic treatment of covid-19, long covid, and related viral infections
US20240173219A1 (en) * 2022-11-29 2024-05-30 Latif Jackson Lotion Composition

Family Cites Families (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU507322A1 (ru) 1973-07-26 1976-03-25 Московский Научно-Исследовательский Институт Косметологии Регул тор гормонального обмена кожи
US3984566A (en) 1974-02-25 1976-10-05 Scott Eugene J Van Method of alleviating the symptoms of dandruff
IT1051853B (it) 1975-01-07 1981-05-20 Basf Ag Butandiol 1.3 3 mono 3 idros sibutirrati butandiol 1.3 1mono 3 idrossibutirrati e processi per la loro preparazione
US4380549A (en) * 1975-07-23 1983-04-19 Scott Eugene J Van Topical treatment of dry skin
JPS54138126A (en) 1978-04-17 1979-10-26 Ajinomoto Co Inc Remedy for diabetes
JPS5747446A (en) 1980-09-05 1982-03-18 Nippon Oil & Fats Co Ltd Nutrious food composition
EP0250559A1 (en) 1985-12-18 1988-01-07 VEECH, Richard L. Parenteral nutrition therapy with amino acids
JPH0755158B2 (ja) 1986-10-30 1995-06-14 チッソ株式会社 光学活性エステルの製造法
US4916074A (en) 1986-10-30 1990-04-10 Chisso Corporation Process for producing optically active compounds
JP2579779B2 (ja) 1987-10-08 1997-02-12 日本車輌製造株式会社 飼料の製造法
BE1001209A3 (fr) 1987-11-19 1989-08-22 Solvay Compositions pharmaceutiques contenant un derive de l'acide 3-hydroxybutanoique choisi parmi les oligomeres de cet acide et les esters de cet acide ou de ces oligomeres avec du 1,3-butanediol.
JPH0383950A (ja) 1989-08-28 1991-04-09 Kanegafuchi Chem Ind Co Ltd グリセリド誘導体およびその製造法
GB8922701D0 (en) 1989-10-09 1989-11-22 Leung Lit Hung Compositions and methods for weight reduction
JP2873497B2 (ja) 1990-09-03 1999-03-24 理化学研究所 脂質代謝調節剤
EP0537113A1 (en) 1991-10-10 1993-04-14 SANDOZ NUTRITION Ltd. Energy supplementary food
JP2884123B2 (ja) 1992-01-17 1999-04-19 高砂香料工業株式会社 生分解性光学活性ポリマー、その中間体オリゴマー、およびそれらの製造方法
US5654266A (en) 1992-02-10 1997-08-05 Chen; Chung-Ho Composition for tissues to sustain viability and biological functions in surgery and storage
US5281691A (en) 1992-06-19 1994-01-25 Eastman Kodak Company Poly(3-hydroxyalkanoates)
JPH06256157A (ja) * 1993-03-03 1994-09-13 Kanebo Ltd 老化防止皮膚化粧料
US5468507A (en) 1993-07-13 1995-11-21 Czap; Al F. Composition containing a desired flavoring agent and medium chain triglycerides
JP3193542B2 (ja) * 1993-09-08 2001-07-30 カネボウ株式会社 皮膚老化防止化粧料
WO1995009144A1 (en) 1993-09-30 1995-04-06 Eastman Chemical Company Nutritive water soluble glycerol esters of hydroxy butyric acid
DE4427492A1 (de) 1994-08-03 1996-02-08 Boehringer Mannheim Gmbh Verfahren zur Analyse einer medizinischen Probe unter Vermeidung von Störbeiträgen aufgrund von Hämolyse
ATE196486T1 (de) 1994-08-10 2000-10-15 Peter Neuenschwander Biokompatibles blockcopolymer
JPH08191664A (ja) 1995-01-12 1996-07-30 Yoshihide Hagiwara 新規コーヒー抽出物の製造法
US6306828B1 (en) 1995-04-06 2001-10-23 Baxter International, Inc. Enantiomerically-enhanced nutritional energy substrates
JP4598203B2 (ja) 1995-12-01 2010-12-15 ビーティージー・インターナショナル・リミテッド 脳機能改善剤
US6126953A (en) 1996-08-19 2000-10-03 The Procter & Gamble Company Fragrance delivery systems for personal care articles
JPH10175855A (ja) 1996-10-16 1998-06-30 Taisho Pharmaceut Co Ltd 肉体疲労改善剤
US6316038B1 (en) 1997-03-17 2001-11-13 Btg International Limited Therapeutic compositions
DK1017379T3 (en) 1997-03-17 2015-02-16 Btg Int Ltd Therapeutic compositions comprising ketone compounds and precursors thereof
US6323237B1 (en) 1997-03-17 2001-11-27 Btg International Limited Therapeutic compositions
US20090253781A1 (en) 2002-05-24 2009-10-08 Btg International Limited Therapeutic compositions
JPH10265378A (ja) 1997-03-25 1998-10-06 Ofutekusu:Kk 角膜上皮損傷治療剤
US6232346B1 (en) 1997-03-27 2001-05-15 Michael J. Sole Composition for improvement of cellular nutrition and mitochondrial energetics
JP3869071B2 (ja) 1997-05-14 2007-01-17 三栄源エフ・エフ・アイ株式会社 甘味食品
CA2289531C (en) 1997-05-15 2009-09-29 University Of Washington Composition and methods for treating alzheimer's disease and other amyloidoses
US6727258B2 (en) 1997-10-29 2004-04-27 King Pharmaceutical Research & Development, Inc. Allosteric adenosine receptor modulators
GB9723590D0 (en) 1997-11-08 1998-01-07 Glaxo Group Ltd Chemical compounds
US6380244B2 (en) 1998-07-22 2002-04-30 Metabolix, Inc. Nutritional and therapeutic uses of 3-hydroxyalkanoate oligomers
DK1123094T3 (da) 1998-09-15 2007-08-20 Btg Int Ltd Terapeutiske præparater (II)
AU6988100A (en) 1999-08-20 2001-03-19 Unilever Plc A method for reducing skin irritation and sting from weak carboxylic acid
PT1248849E (pt) 2000-01-14 2008-09-08 Serono Genetics Inst Sa Cabeça globular obg3 e suas utilizações para reduzir a massa corporal
PT1292294E (pt) 2000-05-01 2009-06-01 Accera Inc Utilização de triglicéridos de cadeia média para tratamento e prevenção da doença de alzheimer
US20070179197A1 (en) 2000-05-01 2007-08-02 Accera, Inc. Compositions and methods for improving or preserving brain function
WO2002006368A2 (en) 2000-07-14 2002-01-24 Metabolix, Inc. Polyurethanes obtained from hydroxyalkanoates and isocyanates
US6970737B1 (en) 2000-09-13 2005-11-29 Ge Medical Systems Information Technologies, Inc. Portable ECG device with wireless communication interface to remotely monitor patients and method of use
AUPR177300A0 (en) 2000-11-29 2000-12-21 Centre For Molecular Biology And Medicine Therapeutic methods
US20050129783A1 (en) 2001-04-19 2005-06-16 Mccleary Edward L. Composition and method for treatment of neurophysiological conditions and maintenance of neurophysiological health
GB0118931D0 (en) 2001-08-02 2001-09-26 Oxford Biosensors Ltd Voltammetric ion-selective biosensor
US7230144B2 (en) 2001-12-18 2007-06-12 Metabolix Inc. Methods of making intermediates from polyhydroxyalkanoates
GB0130684D0 (en) 2001-12-21 2002-02-06 Oxford Biosensors Ltd Micro-band electrode
DE20205184U1 (de) 2002-03-27 2002-12-19 Bartz, Volker, 35440 Linden Blutfettsenker zur oralen Einnahme
GB0211449D0 (en) 2002-05-17 2002-06-26 Oxford Biosensors Ltd Analyte measurement
US8996090B2 (en) 2002-06-03 2015-03-31 Exostat Medical, Inc. Noninvasive detection of a physiologic parameter within a body tissue of a patient
CN1483355A (zh) 2002-09-16 2004-03-24 岚 高 抗疲劳饮料配方
ES2574918T3 (es) 2003-06-02 2016-06-23 Isis Innovation Limited Tratamiento de la fatiga muscular
AU2004245567B2 (en) 2003-06-03 2011-06-23 Oxford University Innovation Limited Nutritional supplements and therapeutic compositions comprising (R)-3-hydroxybutyrate derivatives
JP2005247821A (ja) 2004-02-06 2005-09-15 Ophtecs Corp 炎症性サイトカインの産生を抑制するための眼科用組成物
DE102004007029A1 (de) 2004-02-12 2005-09-08 Consortium für elektrochemische Industrie GmbH Verfahren zur enantioselektiven Reduktion von Ketoverbindungen durch Enzyme
US20050181275A1 (en) 2004-02-18 2005-08-18 Jang Bor Z. Open electrochemical cell, battery and functional device
EP1778213B1 (en) 2004-07-16 2017-04-05 BTG International Limited A method for the synthesis of oligomeric compounds
US20060057691A1 (en) 2004-09-15 2006-03-16 Karunakaran Narasimhan Process for the extraction of polyhydroxyalkanoates from biomass
US8124063B2 (en) 2004-10-25 2012-02-28 Conopco, Inc. Method for moisturizing human skin using dihydroxypropyltri(C1-C3 alkyl) ammonium salts
GB0427145D0 (en) 2004-12-10 2005-01-12 Ketocytonyx Inc Compositions for use in surgery
ITTO20040918A1 (it) 2004-12-29 2005-03-29 Luigi Ambrosio Idrogel polimerici superassorbenti biodegradabili e procedimento per la loro preparazione
WO2007001883A2 (en) 2005-06-20 2007-01-04 Accera, Inc. Method to reduce oxidative damage and improve mitochondrial efficiency
PL1957550T3 (pl) 2005-11-29 2010-06-30 Basf Se Sposób transestryfikacji lub estryfikacji łańcuchów bocznych w polimerach
PT2500017T (pt) 2006-04-03 2017-11-14 Accera Inc Utilização de compostos cetogénicos para tratamento de comprometimento da memória associado à idade
PL2189155T3 (pl) 2006-04-12 2016-07-29 Unilever Nv Doustna kompozycja o przeciwstarzeniowym działaniu na skórę
US7807718B2 (en) 2006-06-30 2010-10-05 Sami A. Hashim Glyceride esters for the treatment of diseases associated with reduced neuronal metabolism of glucose
JP5030553B2 (ja) 2006-11-24 2012-09-19 有限会社ノーベル医学研究所 ドライマウスおよび/または唾液分泌障害を処置するための医薬
RU2446208C9 (ru) 2006-12-19 2012-11-10 Басф Се Применение и способ профилактики или лечения кариеса, вызванного mutans streptococci, отличных от streptococcus mutans
CN101489543A (zh) * 2007-03-14 2009-07-22 汕头大学 提高受试者的学习和/或记忆能力的3-羟基脂肪酸及其衍生物
US20080253997A1 (en) 2007-03-27 2008-10-16 Perscitus Biosciences, Llc Compositions and methods for protecting cells from toxic exposures
JP5065742B2 (ja) 2007-04-18 2012-11-07 三栄源エフ・エフ・アイ株式会社 香味の発現性及び持続性が改善された調味食品
WO2008140828A1 (en) 2007-05-14 2008-11-20 Accera, Inc. Inhibitors of acetyl-coa carboxylase for treatment of neuronal hypometabolism
WO2009023357A2 (en) 2007-05-25 2009-02-19 University Of Rochester Curcumin derivatives and their use as radioprotectors
CA2701179C (en) 2007-10-04 2021-03-16 Nestec S.A. Compositions and methods for enhancing cognitive function
EP2240017B1 (en) 2008-01-04 2019-03-13 Oxford University Innovation Limited Ketone bodies and ketone body esters as blood lipid lowering agents
CN102164884B (zh) * 2008-08-21 2015-03-11 伊希斯创新有限公司 羟基丁酸酯及其医学用途
US8642654B2 (en) * 2009-04-16 2014-02-04 Isis Innovation Limited Hydroxybutyrate ester and medical use thereof
US9034613B2 (en) * 2009-04-16 2015-05-19 Isis Innovation Limited Process for the preparation of (3R)-hydroxybutyl (3R)-hydroxybutyrate by enzymatic enantioselective reduction employing Lactobacillus brevis alcohol dehydrogenase
GB201002983D0 (en) * 2010-02-22 2010-04-07 Tdeltas Ltd Nutritinal composition
FR2958154B1 (fr) 2010-04-01 2012-06-08 Oreal Procede de soin et/ou de maquillage des rides
AU2012219321C1 (en) * 2011-02-17 2016-02-04 Armis Biopharma, Inc. Compositions comprising peroxy alpha-ketocarboxylic acid and methods for producing and using the same
WO2012113415A1 (en) 2011-02-24 2012-08-30 N.V. Nutricia Ketogenic diet composition for the treatment of chemo therapy and/or radiation therapy patients
GB201206192D0 (en) 2012-04-05 2012-05-23 Tdeltas Ltd Ketone bodies and ketone body esters and for maintaining or improving muscle power output
CN104487066B (zh) 2012-07-23 2020-06-09 国立大学法人东京大学 放射线损害的预防和/或治疗剂
JP6883384B2 (ja) 2012-11-05 2021-06-09 ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ 電離放射線による傷害から組織を防護するためのケトン体
GB201304467D0 (en) 2013-03-12 2013-04-24 Tdeltas Ltd Compound for use in protecting skin
SG11201507685UA (en) 2013-03-14 2015-10-29 Isis Innovation Process for producing (r)-3-hydroxybutyl (r)-3-hydroxybutyrate
MY180761A (en) 2013-03-19 2020-12-08 Univ South Florida Compositions and methods for producing elevated and sustained ketosis
GB201314127D0 (en) 2013-08-07 2013-09-18 Tdeltas Ltd Ketone body and ketone body ester for reducing muscle breakdown

Similar Documents

Publication Publication Date Title
Tran et al. Labdane diterpenoids as potential anti-inflammatory agents
MX369229B (es) Metodo para desinfectar semillas comestibles, particularmente semillas productoras de mucilago.
JP2010502701A5 (enExample)
AU2009267471B2 (en) Topical composition for the treatment of actinic keratosis
WO2012085523A3 (en) Skin sanitizer compositions comprising alcohol based emulsion
ATE323473T1 (de) Pharmazeutische zusammensetzungen enthaltend resveratrol und verwendungen davon
US20140127148A1 (en) Fluid composition containing a sun filter, and use thereof for the treatment of scars
RU2015122627A (ru) Кожные композиции, содержащие неприродные гигроскопические аминокислоты
BR112014012463A2 (pt) agente protetor para ceratoconjuntiva ou agente supressor para distúrbio ceratoconjuntival
JP2020504178A5 (enExample)
ES2651188T3 (es) Composición líquida fotopolimerizable
RU2013102294A (ru) Бактерицидные топические композиции
CN104041539A (zh) 一种低毒无害杀虫剂
WO2014008477A3 (en) Activation by physical stimuli and role for trpv4 in organ-specific inflammation and itch
RU2015112839A (ru) Составы, содержащие идебенон, n-ацетил-s-фарнезил-l-цистеин и эрготионеин, и их применение
RU2016148689A (ru) Комбинация тетрапептида и эфира глицерина для лечения андрогенной алопеции
AR098825A1 (es) Composiciones farmacéuticas o cosméticas para uso tópico que comprenden dihidrocloruro de octenidina
RU2017111627A (ru) Композиции для местного применения, содержащие перекрестно-сшитые гликозаминогликаны
JP2015521599A5 (enExample)
ES2635421T3 (es) Composiciones farmacéuticas que comprenden (S)-(+)-7-(1H-imidazol-4-ilmetil)-5,6,7,8-tetrahidro-quinolina para tratar enfermedades y trastornos cutáneos
HRP20191256T1 (hr) Pripravak koji sadrži melatonin ili njegove derivate uz koenzim q10, te njegova upotreba protiv starenja kože
BR112015030352A2 (pt) composições que compreendem um álcool aromático e um antagonista do trpv-1 e usos dessas composições
WO2018101793A3 (ko) 아미드 유도체 화합물, 이의 입체이성질체, 또는 이의 약학적으로 허용 가능한 염, 및 이를 포함하는 피부 노화 억제, 주름 개선, 또는 피부 상처 치료용 약학적 또는 화장료 조성물
HRP20210717T1 (hr) Spoj koji stimulira kolagen i elastin i topikalni sastavi koji sadrže takav spoj
HRP20201508T1 (hr) Spojevi s antioksidativnim djelovanjem protiv slobodnih radikala i protupapalnom aktivnosti te odgovarajući farmaceutski pripravci za njegu kože